StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
COSM reports on 2026-05-20 during the day. Things to look at before the print:
Educational pre-print checklist — descriptive only, not a directional call.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-13 | $0.32 | $0.30 | -4.45% | 0.9M |
| 05-14 | $0.31 | $0.31 | -1.16% | 2.7M |
| 05-15 | $0.31 | $0.30 | -1.57% | 0.5M |
| 05-18 | $0.30 | $0.29 | -2.10% | 1.1M |
| 05-19 | $0.30 | $0.28 | -5.83% | 0.4M |
Finnhub hasn't published the next scheduled earnings date yet. The list typically populates 4–8 weeks before the call.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
These are published opinions from external sell-side analysts — not Stonvex recommendations. Ratings may change without notice, may conflict with each other, and may be wrong. Not investment advice.
Consensus aggregated from publicly disclosed sell-side analyst ratings. Stonvex is not a registered investment advisor and does not endorse any of the ratings shown. Past analyst ratings do not predict future price movements.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Each factor shows COSM's percentile within the scored universe — observational ranking, not a recommendation.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
| Metric | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $65.27M | $45.57M | $28.46M | $13.71M |
Operating Income | $-16.70M | $-5.30M | $-3.48M | $-833.14K |
Net Income | $-19.14M | $-9.00M | $-3.65M | $-818.10K |
EPS (Diluted) | $-0.63 | $-0.32 | $-0.13 | $-0.03 |
Total Assets | $65.48M | $69.49M | $61.84M | $57.19M |
Total Liabilities | $47.05M | $46.36M | $35.60M | $31.24M |
Cash & Equivalents | $715.67K | $889.44K | $655.50K | $742.88K |
Free Cash Flow OCF − CapEx | $-8.50M | $-3.90M | $-1.43M | $-198.85K |
Shares Outstanding | 41.07M | 31.87M | 29.72M | 27.20M |
Latest Form 13F-HR disclosures from the curated Super Investors list. Click through to see each manager's full long book.